Abstract Deadline: May 1Presenting recent advances and emerging areas of lymphoma research
Audio and slides from the NCI Director's Address, the Biden Cancer Initiative Colloquium, and the Plenary Sessions are now available.
Cancer Research Catalyst discusses phase I clinical trials involving immune checkpoint inhibitors presented at the AACR Annual Meeting 2018.
Highlighting the AACR’s progress over the past year in support of our mission
Early Registration Deadline: May 11Discuss the latest innovations in drug development, target selection and the impact of new discoveries in molecular biology.
Stand Up To Cancer takes new approach to multiple myeloma, focusing on precursor conditions
Application Deadline: May 4A three-year grant of $225,000 for projects focusing on DNA Damage Response pathways.
AACR, AACI Visit Capitol Hill to Thank Congress for Prioritizing Funding for Cancer Research
Short-acting Calcium Channel Blockers Were Associated With Increased Risk of Pancreatic Cancer in Postmenopausal Women
TLR9 Agonist CMP-001-Pembrolizumab Combination Shows Early Efficacy in Patients With Metastatic Melanoma Resistant to Anti-PD-1
Latest Advances in Lung Cancer Research
Advances in Malignant Lymphoma
AACR-Johnson & Johnson Lung Cancer Innovation Science Grants
Cancer Dormancy and Residual Disease
